Cite

HARVARD Citation

    Wiesweg, M. et al. (2020). Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutation. Lung cancer. pp. 165-168. [Online]. 
  
Back to record